La Biotronik has obtained FDA clearance for the Vital Data Sensor, a body temperature component within its Biomonitor IIIm Injectable Heart Monitor (ICM).
The ICM is an injectable heart monitor, designed to help cardiologists detect and diagnose cardiac arrhythmias remotely. With the recent addition of a special sensor, the implant now plays an additional role in monitoring for signs of fever. This is especially important right now as the COVID-19 pandemic persists, but it will remain a useful patient monitoring tool even as the current virus recedes.
Biomonitor, the heart is under special surveillance
"Patients are at a high risk of infection during this global pandemic due to their underlying medical conditions," says Dr. By Biase, head of the Electrophysiology section at Montefiore Medical Center. “So it is comforting to know that with our injectable heart monitor we will be able to monitor the first signs of potential cardiac arrhythmias and life-threatening infections for up to 5 and a half years. Coupled with the workflow benefits, this device is a step forward for injectable cardiac monitors. ”
As patients with existing heart conditions are at greater risk with Covid, careful monitoring for early signs of infection could improve the picture. Additionally, this technology can help keep these patients away from hospitals when they don't need to enter, avoiding unnecessary contact and unnecessary stress on the healthcare system.
The future is "sensorial"
"Vital data trends help support diagnosis for a range of diseases, and given the further impact of the current pandemic on heart health, we have urgently worked to advance this sensor technology," added the Dr. David Hayes, Chief Medical Officer of Biotronik Inc. “Closer monitoring of these patients can help manage potential symptoms associated with a febrile response. In particular if it can be done safely and remotely ”.
A "limit" product, this injectable heart monitor, which shows us a possible glimpse of the future. We will also get injected gods sensors to monitor health and know in advance if we are going to get sick?
Here is a quick animation showing how the injectable heart monitor is implanted.
Gianluca Riccio, born in 1975, is the creative director of an advertising agency, copywriter and journalist. He is affiliated with Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists. Since 2006 he directs Futuroprossimo.it, the Italian resource of Futurology.
Futuroprossimo.it is an Italian resource of futurology opened since 2006: every day news about the near future. Scientific discoveries, medical research, prototypes, concepts and predictions about the future for free.
Gianluca Riccio, copywriter and journalist - Born in 1975, he is the creative director of an advertising agency, he is affiliated with the Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists.